Nature 449(7164):804810 Bauer PV, Hamr SC, Duca FA (2016) Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota
In laboratory studies, synthetic BPC-157 is reported to: Support the healing of wounds, and certain injuries Promote recovery after tissue traumas Limit the impact of systemic insults including hyperkalemia and hypermagnesia Promisingly, few studies are reporting any adverse reactions to the administration of BPC 157
Oral antibiotic exposure and kidney stone disease
DESCRIPTION IGF-1 DES (reported as des(1-3)IGF-I in scientific studies) is a truncated version of naturally occurring IGF-1
Different GLP-1 RA have different dosing requirements, such as: Before Meals: Oral semaglutide (Brand name: Rybelsus) taken 30 to 60 minutes before meals Once-daily injections: Lixisenatide (Brand name: Adlyxin) Liraglutide (Brand names: Victoza, Saxneda) Once-weekly injections: Dulaglutide (Brand name: Trulicity) Semaglutide (Brand name: Ozempic) Extended-release exenatide (Brand names: Bydureon, Bydureon BCise) Naturally produced GLP-1 RAs versus GLP-1 Therapies The natural hormone, called endogenous GLP-1 RA produced by the body is released in response to glucose
Unlike native IGF-1, which has a half-life of roughly 20 minutes, IGF-1 LR3 remains active in experimental environments for 2030 hours
